Skip to main content
. Author manuscript; available in PMC: 2022 Apr 15.
Published in final edited form as: FASEB J. 2020 Sep 9;34(11):14182–14199. doi: 10.1096/fj.202000716RR

Fig 1. PFBS promotes proliferation in HTR-8/SVneo cells in a dose-dependent fashion.

Fig 1.

(1A) Cell viability of HTR-8/SVneo cells after PFBS (0, 0.01, 0.1, 1, 10, 100 µM) exposure as measured by MTS assay with an absorbance of 490 nm.

(1B) Cell cycle analysis in HTR-8/SVneo cells treated with PFBS (0, 0.01, 0.1, 1, 10, 100 µM) as measured by flow cytometry.

(1C) Representative immunofluorescent images showing DAPI, Ki-67, and DAPI+Ki-67 staining for HTR-8/SVneo cells treated with PFBS (0, 0.01, 0.1, 1, 10, 100 µM).

(1D) Ratio of Ki-67(+)/DAPI(+) in HTR-8/SVneo cells after PFBS (0, 0.01, 0.1, 1, 10, 100 µM) exposure.